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Abstract
Background: It has recently been demonstrated that saliva from Rhipicephalus sanguineus ticks contains adenosine
(ADO) and prostaglandin E2 (PGE2), two non-protein molecules that have significant immunomodulatory properties.
These molecules can inhibit cytokine production by dendritic cells (DCs), while also reducing the expression of
CD40 in these cells. However, more studies are needed for a better understanding of their participation in the
feeding of ticks in vivo. This work, therefore, evaluated the importance of ADO during tick infestations. Mice were
infested with adult ticks (3 couples/mouse), and their skin was collected at the tick-infested site (3rd and 7th day),
and mRNA for receptors of ADO was quantified by real-time PCR.
Results: Tick infestation increased by four and two times the expression of the A2b and A3v1 receptors on day 3,
respectively, while expression of other ADO receptors was unaltered. In addition, we treated mice (n = 10/group) daily
with 8-(p-Sulfophenyl)theophylline, 8-pSPT, 20 mg/kg, i.p.), a non-selective antagonist of ADO receptors, and evaluated
the performance of ticks during infestations. Female ticks fed on 8-pSPT-treated mice presented a reduction in their
engorgement, weight and hatching rates of egg masses, and survival times of larvae compared to the same parameters
presented by ticks in the control group. To investigate if these 8-pSPT-treated mice presented altered immune responses,
we performed three tick infestations and collected their lymph node cells to determine the percentages and activation
state of DCs and cytokine production by lymphocytes by flow cytometry (Cytometric Bead Array technique, CBA). Our
data showed that 8-pSPT-treated mice presented an increase in the percentage of DCs as well as of their stimulatory and
co-stimulatory molecules (CD40, CD80 and MHCII). Regarding production of T cell cytokines, we observed a significant
increase in the levels of IL-2 and a significant decrease in IL-10, IL-17, TNF-α and IFN-γ cytokines.
Conclusions: These results suggest that ADO produced by ticks helps them feed and reproduce and that this effect may
be due to modulation of host DCs and T cells.
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Background
Over the past few years, the brown dog tick (Rhipicepha-
lus sanguineus) has taken a very important role among the
species of ticks in Brazil and worldwide [1–3]. This is due
to the direct effects of parasitism and the transmission of
disease-causing agents to both dogs and humans [4–8].
The R. sanguineus-host interaction at the skin feeding site
is complex. Thus, to succeed during the parasitic phase,
these ticks need to overcome the barriers imposed by the
host response [9–12]. The first barrier is represented by the
hemostatic system, while the second one is imposed by im-
mune cells and molecules of innate and acquired immune
response. The hemostasis and immune response appear
during the tick attachment phase when the arthropod
breaks the physical barrier of the host (skin) and inoculates
its saliva to facilitate their access to blood, as well as escape
from other host defences systems [11, 13].
* Correspondence: elen.anatriello@unifesp.br
1Institute of Science and Technology, Federal University of São Paulo,
UNIFESP, Rua Talim, 330, São José dos Campos, São Paulo 12231-280, Brazil
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Anatriello et al. Parasites & Vectors  (2017) 10:326 
DOI 10.1186/s13071-017-2248-8
The number and variety of anti-hemostatic and immu-
nomodulatory components present in tick saliva are so
vast that this parasite has been considered a “profes-
sional pharmacologist” and has been studied as a source
of numerous therapeutic targets [11, 14–16]. The anti-
hemostatic and immunomodulatory activities of tick
saliva [11–13, 17] include the modulation of vasodilation
[17, 18], inhibition of platelet aggregation [19], reduction
of T lymphocyte proliferation and function [20, 21], sup-
pression of the activity and production of cytokines and
chemokines [21–23], inhibition of maturation and func-
tion of macrophages [21, 23, 24], dendritic cells (DCs)
[25–29], neutrophils [30], mast cells and natural killer
(NK) cells [24], and containment of mediators essential
for rash and pain induction [31].
Given the induction of innate and acquired immune
response is triggered mainly by DCs, since they are spe-
cialised in activating naïve lymphocytes and initiating
primary immune responses [32], our group has investi-
gated, whether the modulation of immune response me-
diated by tick infestation is dependent on these cells. We
have shown that the saliva of R. sanguineus ticks
inhibits DCs differentiation, reduces the expression of
stimulatory and co-stimulatory molecules like CD40,
CD80 and CD86, and modulate DCs cytokine produc-
tion [26–28]. Moreover, we showed that its effect, at
least in vitro, is dependent in part on adenosine
(ADO) and prostaglandin E2 (PGE2), two non-protein
molecules contained in the saliva that have multiple
immunomodulatory properties [29].
ADO is an endogenous purine nucleoside that modu-
lates a wide variety of functions in several cells of the
immune system, including DCs, T and B cells, within
others [33–36]. In order to exert its activity, ADO binds
specifically to a family of four G-protein receptors,
named A1, A2a, A2b, and A3 receptors. Interestingly,
ADO exercises its anti-inflammatory/ immunosuppres-
sive effects by binding to the A2a and A2b receptors,
whereas the binding to the A1 and A3 receptors results
in pro-inflammatory actions [37–39].
Importantly, ADO has been identified in salivary
glands of other classes of hematophagous arthropods,
notably, the sand flies Phlebotomus argentipes and
Phlebotomus duboscqui [40, 41]. In addition, it has
been shown that ADO and AMP in Phlebotomus
papatasi saliva mediate the exacerbating effects of
Leishmania infection by promoting a tolerogenic pro-
file in DCs and by differentiating inducible T regula-
tory cells in the inflammatory site through an A2a
receptor mechanism [42].
The present study evaluated, for the first time, the in
vivo participation of ADO during infestation of mice by
R. sanguineus ticks. We studied the expression of ADO
receptors, the feeding and reproductive parameters of
ticks, and the immune response of tick-infested mice
treated or not with a non-selective antagonist of ADO
receptors. Moreover, we tested if knockout (KO) mice
for A2a receptors were enhanced in their resistance to
ticks. The study of the role of ADO in a tick infestation
can contribute to a better understanding of the tick-host
interface.
Methods
Colony of ticks and infestation
Rhipicephalus sanguineus ticks were laboratory-reared as
previously described [43]. For tick infestation experi-
ments, BALB/c mice (10 animals per group) were
infested with three pairs of adult R. sanguineus ticks
restricted in plastic feeding chambers fixed to their
backs, as previously described [21]. BALB/c mice were
three times tick-infested (7–15 days/per infestation),
with an interval of 30 days between each infestation,
and animals were treated daily with a non-selective
antagonist of ADO receptors (8-pSPT, 20 mg/kg i.p.) or
with saline (see Table 1 for the experimental design).
During the successive infestations (always on different
skin sites), the ticks were evaluated for their biological
parameters, i.e. the average weight of the engorged
females, egg mass weight, reproductive index, larva
hatching rate and larva survival period. In all the exper-
iments of infestation we added a group of Sham
animals, a control group consisted of mice that had the
chamber fixed to their backs, but had no ticks released.
This group was relevant to avoid misinterpretations
due to the effect of the glue used to fix the chambers.
Table 1 Experimental design
Analysed parameters Groups
First infestation on
WT mice
First and second infestation
+8-pSPT-treated WT mice
Third infestation +8-pSPT-
treated WT mice
First and second infestation
on A2aR−/− mice
Expression of the ADO and PGE2 receptors − − − −
Performance of ticks − + − +
Expression of stimulatory and
co-stimulatory molecules
− − + −
Cytokine production − − + −
+, Done; −, Not done; 8-pSPT, non-specific antagonist for ADO receptors
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Mice
BALB/c and KO mice for A2a receptors (A2Ar−/− mice
on a BALB/c background) [44] 6-week USA) and bred/
maintained at the Central Animal Facility of the School
of Medicine-USP, Ribeirão Preto. These animals were
housed in temperature-controlled rooms (22–25 °C) and
received water and food ad libitum.
Real-time polymerase chain reaction for ADO receptors
(A1, A2a, A2b and A3v1 and A3v2) and PGE2 receptors
(EP1, EP2, EP3 and EP4)
Skin samples frommice one-time tick-infested (3 and 7 days
tick-infested) or non-infested (Sham animals; control
group) were collected from the area where the ticks were
attached or the corresponding site on the Sham mice and
placed into a metal block (Biospec, Bartlesville, OK, EUA),
added to liquid nitrogen and pulverized using a hammer.
The total RNA was extracted using the TRIzol reagent
(Invitrogen, Carlsbad, CA, USA) and the SV Total RNA Iso-
lation System Kit (Promega, Madison, WI, USA), according
to the manufacturer’s instructions. Complementary DNA
was synthesised using ImProm-II TM Reverse Transcription
System (Promega, Madison, WI, USA). SYBR Green Mix-
based quantitative real-time PCR assays were performed
using the StepOnePlus Real-Time PCR System (Applied
Biosystems, Singapore, Malaysia). The mean threshold cycle
(Ct) values of measurements were used to calculate the
expression of the target gene, which was normalised to the
housekeeping gene β-actin, using the 2-ΔΔCt formula.
The primers were the following: A1: 5′-GTT GCC
AGC AGT TTT GCC CAC TC-3′, 5′-AGC CCG CAG
GGG CTC ATA TCA-3′, A2a: 5′-TTC TTC GCC TGC
TTT GTC CT-3′, 5′-ATA CCC GTC ACC AAG CCA
TT-3′, A2b: 5′-CTG CTC ATA ATG CTG GTG ATC
T-3′, 5′-ATC AGT TCC ATG CGC TGA-3′, A3v1
(isoform 1): 5′-CTA CGC CTG CAA AAT AAA AAA
G-3′, 5′-GTC CAA AGA ATC TGA GGT CTG A-3′,
A3v2: isoform 2): 5′-CAA AAG CAT CAG TAG AAA
CCC A-3′, 5′-ACC GCA CTT CAA ATC CTT GCC-3′,
β-actin: 5′-CCT TCC TTC TTG GGT ATG GAA T-3′,
5′-TGG CAT AGA GGT CTT TAC GGA T-3′, EP1: 5′-
GTT GCC AGC AGT TTT GCC CAC TC-3′, 5′-AGC
CCG CAG GGG CTC ATA TCA-3′, EP2: 5′-GGC CGG
AAG GGA GCT CTG GA-3′, 5′-CGG AGG GTC TGA
TGG CCC CA-3′, EP3: 5′-GCT ATC CCG CAG CTG
AGC CG-3′, 5′-GGG AAA GGC CAC GGA CAC GG-
3′, EP4: 5′-GGT CCT GAA CAT CTG AGG CCT GAG
C-3′, 5′-CGC GTT GAC TCC GGG GAT GGA-3′.
Evaluation of biological and reproductive parameters of
ticks feeding on mice treated or not with an ADO
receptor antagonist or KO mice for A2a receptors
To investigate the in vivo participation of ADO during
an infestation of mice by R. sanguineus ticks, we treated
mice with an antagonist of ADO receptors and infested
mice deficient for A2a receptors.
For the assay with the ADO receptors antagonist,
BALB/c mice were infested three times (interval of
30 days between infestations) with three couples of R.
sanguineus adult ticks and treated daily with a non-
selective antagonist of ADO receptors (8-pSPT, 20 mg/
kg/100 μl i.p.) or saline (n = 10 per group) throughout
all infestations (9–13 days/infestation). After tick detach-
ment, the biological and reproductive parameters were
measured (average weight of the engorged females, egg
mass weight, reproductive index, larva hatching rate and
larva survival period). The reproductive index was calcu-
lated by dividing the egg mass weight (g)/female
engorged weight (g) × 100. The biological and repro-
ductive parameters of the ticks were only measured on
the first and the second infestations since the mice
infested three times were killed and used to evaluate
DCs activation and cytokine production on the third or
seventh day of the third infestation.
To test if KO mice for A2a receptors (A2aR−/−) would
present enhanced resistance to ticks, BALB/c A2aR−/−
mice and wild-type mice (WT) (n = 10 per group) were
one-time tick-infested with three couples of R. sangui-
neus adult ticks and evaluated for similar biological and
reproductive parameters as described above, added to
the determination of the engorged female number
detached for each group.
Evaluation of DCs activation and cytokine production
after treatment with ADO receptor antagonist in mice
infested with ticks
BALB/c mice were infested three times (interval of
30 days between the infestations) with three pairs of R.
sanguineus ticks. These animals were treated daily with
8-pSPT (20 mg/kg, i.p.) or saline. Mice were killed on
the third and seventh day (3D and 7D) of the third
infestation and cells from lymph nodes draining the
infestation site (axillary and brachial lymph nodes) were
cultured with and without Concanavalin A (Con-A;
2 mg/mL). After 24 h of culture at 37 °C in 5% CO2, the
supernatants were collected and stored at -80 °C until
use. To study DCs activation, the cells were labelled with
monoclonal antibodies conjugated with fluorochromes
against CD11c, CD80, CD86, CD40 and MHCII (I-A/I-E)
molecules (Biolegend, San Diego, CA, USA). Briefly, after
cells were fixed in PBS plus 2% formaldehyde, they were
incubated for 30 min with the specific antibodies. Subse-
quently, the cells were washed with a permeabilization
buffer (PBS added fetal bovine serum 1%, sodium azide
0.1% and saponin 0.2%), followed by washing with PBS and
re-suspension in 100 μl of PBS. Fluorescence was mea-
sured on an FACSCanto Reading II (Becton Dickinson,
San Jose CA, USA) obtained in 100,000 events/sample and
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analysis were performed using the Flow Jo software
(TreeStar, Ashland, OR, USA). DCs were firstly gated
based on their characteristic of size (FSC) and granu-
larity (SSC), and secondly for the expression of
CD11c, MHCII, CD40, CD80 and CD86 markers.
The cytokine levels in the supernatants were deter-
mined by Cytometric Bead Array (CBA technique) using
the mouse Th1/Th2/Th17 CBA Kit following the manu-
facturer’s instructions (BD Biosciences, San Jose, CA,
USA). Cytokine analysis was performed on the BD™
FACSCanto Reading II (BD Biosciences). All the quanti-
tative analysis was done using FCAP Array™ Software
(BD Biosciences).
Statistical analysis
Data were analysed using GraphPad PRISM 5.0 soft-
ware (GraphPad Software Inc., La Jolla, CA) and pre-
sented as mean ± SEM. Comparisons between animal
groups were performed using unpaired Student t-test,
or the Mann-Whitney test for samples with nonpara-
metric distributions.
Results
Tick infestation increased mRNA expression of the ADO
receptors A2b and A3v1 in mouse skin
The results showed that the tick infestation (just one
infestation) induced a four and a two-fold increase in
the mRNA expression of A2b and A3v1 receptors, re-
spectively on day 3, while no other ADO receptors were
significantly altered when compared with the Sham con-
trol; control group (Fig. 1). In addition, on the 7th day of
infestation, both groups responded similarly. We also in-
vestigated the expression of mRNA for PGE2 receptors
(EP2, EP3 and EP4), and the results showed that the skin
of mice infested with ticks presented unchanged mRNA
expression for PGE2 receptors at the time points
analysed (Table 2).
Treatment of mice with an ADO receptor antagonist
reduced tick-feeding performance on the first infestation
We treated mice daily with 8-pSPT, a non-selective
antagonist of ADO receptors, during the first and
second infestation to evaluate the performance of ticks
during an infestation when ADO signalling is blocked.
Fig. 1 The relative mRNA expression of the ADO receptors in mice skin. Skin samples from one-time tick-infested and sham BALB/c mice; control
group (5 to 9/group) were collected on the 3rd and 7th day (3D and 7D) after infestation and processed for assessment of gene expression of
receptors for adenosine by real-time PCR. Data are presented as mean values ± SEM of relative expression of A1 (a), A2a (b), A2b (c), A3v1 (d)
and A3v2 (e) mRNA for a target gene normalized for RNA expression of the housekeeping β-actin gene
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In the first infestation, we observed that ticks fed on
8-pSPT-treated mice presented a significant reduction in
several biological parameters analysed; i.e. engorgement
weight of females, egg mass, hatching rate and the larva
survival period (P < 0.05). The engorgement weight of
females showed an average of 0.155 g for ticks fed on
the control mice, with a variation ranging from 0.115 to
0.186 g, while for the 8-pSPT-treated mice the mean
weight was 0.115 g, with a range from 0.017 to 0.156 g
(Mann-Whitney U-test: U(8)= 12, P = 0.03, Fig. 2a). For
the egg mass, the mean value was 0.084 g (ranging from
0.053 to 0.104 g) and 0.058 g (ranging from 0 to 0.086 g)
Table 2 The relative mRNA expression of the PGE2 receptors in one-time tick-infested and non-infested (sham group; control group)
mice skin
Expression of the target gene normalised to the housekeeping gene β-actin using the 2-ΔΔCt formula
Groups EP2 EP3 EP4
3D control 1.543 ± 1.175 0.843 ± 0.475 1.001 ± 0.042
3D infested 0.395 ± 0.195 0.634 ± 0.463 0.432 ± 0.186
P-value 0.29 0.78 0.09
7D control 1.054 ± 0.219 1.003 ± 0.055 1.623 ± 1.103
7D infested 0.693 ± 0.183 0.749 ± 0.281 1.766 ± 0,665
P-value 0.26 0.48 0.91
N = 3–5/group; D, days
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Fig. 2 Performance of ticks feeding on mice treated with an ADO receptor antagonist. BALB/c mice (n = 10/group) were infested with three
couples of adult ticks and treated daily with a non-selective antagonist of ADO (8-pSPT, 20 mg/kg i.p.) or saline. After tick detachment, female
ticks were weighed (a) and placed in a chamber for oviposition. The egg mass weight (b) was measured 15 days after the engorged female tick
detachment and after the reproductive index (c) larva hatching rate (d) and larva survival period (e) was calculated. Data are presented as mean
values ± SEM from two independent experiments
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for ticks fed on control and 8-pSPT-treated mice,
respectively (t-test: t(8) = 2.343, P = 0.03, Fig. 2b). Ana-
lysis of the hatching rate and the larva survival period, re-
vealed a reduction of 32% and 20% respectively, between
the treated and untreated mice (Mann-Whitney U-test:
U(8) = 10, P = 0.004; Fig. 2d and Mann-Whitney U-test:
U(8) = 8, P = 0.01, Fig. 2e). The only parameter that was
not changed between the groups was the capacity of
female ticks to transform the ingested blood into eggs
(Mann-Whitney U-test: U(8) = 16, P = 0.10; i.e. repro-
ductive index; Fig. 2c).
During the second infestation, the unique tick param-
eter that changed between the mice treated with the
antagonist (8-pSPT) and the controls was the larva
survival period, which was reduced by 12% on the
antagonist-treated group (Table 3).
So far, our results suggest that the blockade of ADO
receptors particularly affected the performance of ticks
during the first infestation (Table 3).
Deficiency of the A2a receptor in mice did not impair the
biological and reproductive parameters of ticks during
infestation
Tick-infested A2aR−/− mice did not present change in
the number of engorged females, the weight of the
engorged females, egg mass weight, reproductive index
and larva hatching rate (Table 4).
Treatment of tick-infested mice with an ADO receptors
antagonist modulated DCs and altered lymph node
cytokine production
To investigate whether treatment with 8-pSPT alters the
immune response of mice infested with ticks, we per-
formed one more infestation (third infestation) and
collected the draining lymph nodes to determine the ex-
pression of stimulatory and co-stimulatory molecules
CD40, CD86, CD80 and MHCII on DCs (CD11c+ cells)
as also the production of cytokines.
Our data showed that on the third day of infestation,
the 8-pSPT-treated group presented a significant in-
crease in the percentage of DCs (CD11c+) (t-test:
t(8) = 3.576, P = 0.002) and CD11c
+ CD40+ cells (t-test:
t(2.973) = 2.973, P = 0.01) compared to the controls,
however the same was not detected on the seventh day
(Fig. 3a-d). Furthermore, the treatment with 8-pSPT in-
duced a significant increase in the percentage of CD11c
+MHCII+ cells in the both days evaluated (Fig. 3c), while
an enhanced frequency of CD11c+CD80+ cells was
observed only on the seventh day (Fig. 3e). Concerning
the percentage of CD11c+CD86+ cells, no significant
differences between the 8-pSPT-treated or control group
were observed (data not shown).
To investigate the effect of the 8-pSPT treatment on
the cytokine production by cells of the lymph nodes of
tick-infested mice, we stimulated the cell cultures with
Con-A and the Th1, Th2 and Th17 cytokines profiles in
the supernatant were measured by CBA (Fig. 4). On the
third day of the third infestation, the production of IL-2
increased by 10 times for the cells of 8-pSPT-treated
mice compared the control group (Mann-Whitney U-
test: U(6) = 1, P = 0.004) (Fig. 4a). Additionally, on the
same third day, the treated group showed a significant de-
crease in the production of IL-17 (Mann-Whitney U-test:
U(6) = 0, P = 0.002), TNF-α (t-test: t(6) = 2.810, P = 0.01),
IFN-γ (Mann-Whitney U-test: U(6) = 4, P = 0.02) and IL-
10 compared to the controls (Mann-Whitney U-test:
U(6) = 0, P = 0.002) (Fig. 4d-g). No differences in the pro-
duction of IL-4 and IL-6 were detected in the superna-
tants of cells from both groups (Fig. 4b, c).
Discussion
It is known that the expression of ADO and PGE2
receptors is regulated during physiological and patho-
logical stress [45] when both are upregulated to suppress
cell activity. As previously described, R. sanguineus ticks
produce high concentrations of ADO and PGE2, which
accumulate in tick saliva and are inoculated into the
Table 3 Biological parameters analysed on tick-infested mice treated with 8-pSPT or saline
Groups Engorged female weight (g)
± SEM
Egg mass weight (g)
± SEM
Reproductive index
± SEM
Larva hatching rate (%)
± SEM
Larva survival period (days)
± SEM
First infestation
Saline 0.155 ± 0.01 0.084 ± 0.01 54.19 ± 1.67 88.56 ± 0.44 42.50 ± 0.59
8-pSPT 0.115 ± 0.01 0.058 ± 0.01 44.19 ± 6.46 66.63 ± 12.58 33.86 ± 3.07
P-value 0.04* 0.03* 0.16 0.01* 0.01*
Second infestation
Saline 0.131 ± 0.01 0.078 ± 0.01 58.96 ± 2.08 83.57 ± 3.95 45.71 ± 1.59
8-pSPT 0.105 ± 0.01 0.055 ± 0.01 46.36 ± 7.35 77.13 ± 11.99 40.14 ± 1.66
P-value 0.18 0.12 0.14 0.24 0.03*
*P <0.05 comparing the 8-pSPT-treated group with the control group (saline)
N = 10/group; 8-pSPT, non-specific antagonist for ADO receptors
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host skin during feeding [29]. This was also reported for
other tick species, such as Amblyomma americanum for
ADO [46] and Dermacentor variabilis for PGE2 [47].
The latter showed that ticks use salivary PGE2 to impair
macrophages to produce pro-inflammatory mediators
and recruit fibroblasts to the feeding site, consequently
inhibiting wound healing [47]. Therefore, a better under-
standing of the dynamic of expression of ADO and
PGE2 receptors in the host skin during an infestation
can help to unravel the role of these molecules in the
success of the tick to achieve a good blood meal.
Here, we demonstrate that there is a significant in-
crease in gene expression for the A2b and A3v1 recep-
tors on the third day of a tick infestation on BALB/c
mice. Previously, others have demonstrated that the A2b
and A3 receptors are upregulated in inflammation, stress
or injury and that blocking them with the use of select-
ive antagonists can be used as a treatment for inflamma-
tory diseases, such as Parkinson’s disease, ischemia and
cancer [36, 48–52]. Our study also showed that on the
seventh day of infestation, the A2b and A3v1 receptors
expression returned to control values. This may have
happened because of the large volume of tick saliva
already released into the host skin, which contains a
variety of other immunosuppressive molecules that can
modulate the inflammation independently from the
ADO signalling pathway [11, 13].
In regard to the expression of mRNA for PGE2 recep-
tors (EP2, EP3 and EP4), these were unchanged during
the tick infestation at the time points analysed (data not
shown), while EP1 receptor was not detected in the skin
of mice, regardless they were infested or not with ticks
(data not shown). This latter observation corroborates
other studies that show that, unlike other PGE2 recep-
tors, the EP1 receptor is not expressed in the skin of
mice [53].
Concerning that tick infestation modulates the expres-
sion of mRNA for A2b and A3v1 receptors in mice, we
treated them daily with a non-selective antagonist of
ADO receptors (8-pSPT) during the first and second in-
festation to evaluate the importance of ADO signalling
pathway in the performance of ticks. Data indicate that
the blockade of ADO receptors induces a significant
reduction in the biological and reproductive parameters
of ticks during the first infestation on mice, whereas
during the second infestation this did not occur. A pos-
sible explanation can be that ticks produce different
components within the time-course of feeding [54, 55].
Thus, additional regulatory molecules can be introduced
into the host by the 7th day of infestation.
Although not having found a difference in the expres-
sion of A2aR on tick infested mice and knowing that
ADO from Phlebotomus papatasi can suppress the
immune response via A2aR [42], we tested if the lack of
this receptor in mice (A2aR−/−) could reduce tick infest-
ation performance. Our results indicated that this defi-
ciency was not enough to compromise tick-feeding
success, suggesting that other receptors (i.e. A2bR and
A3v1R) are involved in the immunosuppression. This
possibility has yet to be tested.
Our results indicate that ADO of tick saliva possibly
plays an important role in suppressing host immune/in-
flammatory mechanisms, at least in the initial phase of
tick feeding. This can happen, since other studies show
that ADO can reduce the expression of adhesion mole-
cules in endothelial cells, resulting in a decrease of
leukocytes rolling, adhesion and migration to inflamed
tissue [56, 57]. In addition, ADO can also increase vaso-
dilation and may inhibit platelet aggregation [58, 59],
modifications that may well assist ticks while they feed.
Tick saliva also impairs the differentiation and bio-
logical activity of DCs by reducing their stimulatory and
co-stimulatory molecules in vitro, and this was associ-
ated to ADO [26–29] and other molecules, such as Salp
15 and Japanin [25]. Moreover, others have shown that
the A2b receptor is the mediator of ADO effects on
DCs, which results in impaired maturation (reduced
expression of MHCII and CD86) and immunogenicity of
DCs [35, 60]. Our data demonstrate that blocking ADO’s
receptors (8-pSPT-treated mice) can increase the
percentage of DCs, as also as their activation state
(augmented expression of CD40, CD80 and MHCII).
It seems that compromising the initial steps of the
immune response to inhibit the differentiation and
maturation of DCs into functional antigen-presenting
cells can impair tick rejection by the host.
Besides being a non-selective blocker of adenosine
receptors, 8-pSPT (theophylline) also presents a
Table 4 Biological parameters analysed on WT and A2aR−/− tick-infested mice
Groups Engorged
female (%) ± SEM
Engorged female
weight (g) ± SEM
Egg mass
weight (g) ± SEM
Reproductive
index ± SEM
Larva hatching
rate (%) ± SEM
First infestation
WT 33 ± 7.02 0.105 ± 0.02 0.69 ± 0.01 56 ± 3.85 61 ± 45
A2aR−/− 53 ± 12.37 0.113 ± 0.01 0.69 ± 0.01 53 ± 2.86 88 ± 25
P-value 0.11 0.74 0.98 0.65 0.06
N = 10/group
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phosphodiesterase (PDE) inhibitor activity [61]. The
effect of selective inhibition of PDE4 (the main PDE
expressed in immune cells) includes reduced secre-
tion of IL-12 and TNF-α by DCs and impaired cap-
acity to promote Th1-polarized responses [62, 63].
Impaired secretion of IL-12 and TNF-α by DC was
observed in our work after 8-pSPT treatment, what
could suggest some influence of PDE inhibition, even
though theophylline is considered a weak inhibitor
of PDE4, compared with its inhibitory activity on A1
and A2 ADO receptors [64]. However, we also ob-
served a decreased production of IL-10 by DCs,
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Fig. 3 DCs activation after treatment with ADO receptor antagonist in mice infested with ticks. BALB/c mice (n = 6/group) were three times tick-
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contrasting with the already described enhancement
of IL-10 secretion by immune cells when PDE4 is
inhibited [65]. Indeed, the increase of IL-10 is seen
when DCs are stimulated with the non-selective
ADO agonist NECA [35] and during tick infestations
[66], while the treatment of DCs with a selective an-
tagonist of the A2B receptor (which is upregulated
during tick infestation, Fig. 4) impairs IL10 produc-
tion [35]. In addition, PDE4 selective inhibition did
not promote up-regulation of surface expression of
HLA-DR, CD40 and CD80 like was observed when
DCs were cultured in the presence of a non-selective
agonist of ADO receptors NECA [35], corroborating
our reasoning. Broadly, the DC phenotype promoted
by PDE4 inhibition is similar to the phenotype
presented during tick saliva’s stimulus and is related
with mice susceptibility to ticks, and not resistance,
as shown in our work, what strongly suggests that
our results are more to be due to ADO signalling
than PDE signalling.
We have previously shown that ADO from tick saliva
modulates cytokine production, downregulating IL-
12p40 and TNF-α, and upregulating IL-10 production
by DCs [29]. In line with this report, it has been shown
that ADO from human and mice impairs TNF-α, IL-6,
and IL-12 production, while it augments secretion of IL-
10 by DCs and macrophages [67–69]. Here we have
shown that the ADO receptors blockade can revert the
modulation by tick saliva. In this way, tick-infested mice
treated with 8-pSPT induced a mixed cytokine profile,
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with a decrease of TNF, IFN-γ, IL-10 and IL-17 and in-
creased of IL-2 production. The reduction of IL-17 is in
line with other studies that show that, in autoimmune
diseases models, the blockade of A2b receptors dimin-
ishes Th17 type cytokines [70]. On the other hand, the
A2b receptor has also been shown to modulate the IL-6
production [71], a phenomenon that was not seen in this
study.
Others have shown that ADO, per se, also inhibits
T cell proliferation and reduces the synthesis of IL-2
[36, 56, 72, 73], while can increase the numbers of T
regulatory cells through an increase in IL-10 at the
inflamed site, which can inhibit the activity of effector T
cells [74]. Moreover, the inhibition of T cell proliferation by
ADO has been shown to occur via activation of the A2b
receptor [75, 76]. Related to the role of A3 receptors in
inflammation there is still a controversial debate. Some
studies found that A3 receptor activation can improve
inflammatory mediators release and degranulation in mast
cells, suggesting a pro-inflammatory role [77, 78]. Other
works have shown that its activation can suppress TNF-α
release from LPS-stimulated macrophages and superoxide
production and chemotaxis of neutrophils besides its com-
petence to suppress the proliferation T cells [34, 78–81].
Interestingly, a recent study indicates a common associ-
ation of the A3 receptor with potent analgesic effect in
rodent models of chronic pain [82]. Maybe tick saliva’s
ADO signs via A3 receptor in the early phase of feeding, so
it can get its blood meal properly by blocking pain.
Conclusion
Taken together, the results demonstrate that ADO, pre-
viously identified in the saliva of ticks, can bind to A2b
and A3 receptors on host cells. As doing so, it inhibits
the function of diverse cells of the host immune re-
sponse, including dendritic and T cells, modulating both
the innate immune response and the acquired immune
response, inducing a mixed T cell type response that
facilitates tick-feeding and reproduction.
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